News
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: fox e-mobility AG: from a pure electric vehicle developer to an investment group focused on sustainable energy and sustainable mobility solutions
Fox e-mobility AG transforms from electric vehicle developer to investment group, focusing on sustainable energy and mobility solutions. Agreements with a Liechtenstein-based financial investor enable this transition -
COMMUNIQUÉ DE PRESSE
VeonGen Announces Clinical Progress of VG801 Gene Therapy in Stargardt Disease, with an Oral Presentation at ARVO 2026
VeonGen announces positive clinical progress of VG801 gene therapy for Stargardt Disease, including FDA and RMAT support, with promising efficacy and safety profile. Presentation at ARVO 2026 -
-
COMMUNIQUÉ DE PRESSE
Waterdrop Q4 and FY2025 Financial Results: Q4 operating revenue rises 105.5% YoY, and declared a cash dividend
Waterdrop Inc. reports a 105.5% increase in Q4 operating revenue and a cash dividend. FY2025 shows a 43.5% revenue rise and RMB568.9 million profit. AI integration drives operational efficiency and growth -
COMMUNIQUÉ DE PRESSE
Bitmine Immersion Technologies (BMNR) Announces Launch of MAVAN (Made In America VAlidator Network), the Company's Proprietary Staking Solution
Bitmine Immersion Technologies launches MAVAN, the largest Ethereum staking platform globally, providing services for proof-of-stake chains and blockchain infrastructure -
COMMUNIQUÉ DE PRESSE
Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Prince Silver Corp. announces completion of NI 43-101 Technical Report on Stampede Gap Project, Nevada, highlighting exploration potential in copper, gold, silver mineralization -
COMMUNIQUÉ DE PRESSE
Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Zentek's Triera, with a 20-year McMaster University license, offers CRO services for custom aptamer discovery and biosensor enablement in infectious disease and oncology markets -
